ExodusPoint Capital Management, LP - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 142 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.

Quarter-by-quarter ownership
ExodusPoint Capital Management, LP ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$589
-3.0%
23,037
+8.8%
0.01%
+20.0%
Q2 2023$607
-16.0%
21,176
-29.8%
0.01%
-16.7%
Q1 2023$723
+42.9%
30,164
+1.2%
0.01%
-14.3%
Q4 2022$506
-99.9%
29,816
-37.3%
0.01%
-22.2%
Q3 2022$705,000
-32.7%
47,552
+116.8%
0.01%
-35.7%
Q3 2021$1,048,000
+3.7%
21,937
-5.9%
0.01%
+40.0%
Q4 2020$1,011,000
-36.4%
23,302
-37.1%
0.01%
-68.8%
Q3 2020$1,590,000
+1214.0%
37,055
+232.8%
0.03%
+1500.0%
Q4 2019$121,00011,1350.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q4 2021
NameSharesValueWeighting ↓
Green Alpha Advisors, LLC 8,394$264,6630.19%
Global Wealth Strategies & Associates 100$3,1530.00%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders